However, both treatments produced only slight changes in the levels of total BCL2 and BECLIN1 proteins (Fig. 3a), indicating that they cannot be used confidently as markers for immediate autophagy evaluation in neuroblastoma cells when only a single temporal point is available for testing. Here, BCL2 is linked to neuroblastoma.